{"keywords":["TP53 mutation","acute myeloid leukaemia","hypomethylating agents","older age","treatment"],"genes":["TP53"],"publicationTypes":["Letter"],"title":"Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia.","pubmedId":"27431572"}